In humans, increases in GDF15 are seen with metformin-induced weight loss [132] and exercise training [134], suggesting that higher circulating GDF15 levels linked to metabolic disease are not causative, but rather because of the metabolic stress from obesity and NAFLD. Here, GDF15 is linked to metabolic dysfunction-associated steatotic liver disease.